Medanta doctor suggests adopting Monoclonal antibody drugs early to treat COVID patients

New Delhi, May 30 (ANI): Dr. Arvinder Singh Soin, Chairman, Institute of Liver Transplantation and Regenerative Medicine, Medanta talked about Monoclonal antibody drugs and said, “While we have been treating COVID with repurpose drug there is finally some good news for India. The US now has 3 Monoclonal antibody drugs. We should adopt these early, make arrangements to manufacture them in India at scale and make them available at low cost”.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting